Device Trial Radar · NCT02675751
Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced Wavescan Studio™ System and Star S4 IR™
Last checked: Nov 20, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
167
Actual
Start
Feb 3, 2016
Primary completion
Jul 27, 2018
Study completion Jul 27, 2018
Sponsor
- Lead sponsor
- Abbott Medical OpticsPublic (ABT)
- Sponsor type
- Industry
- First posted
- Feb 5, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, multicenter, bilaterally-treated, open-label, non-randomized clinical trial.
Conditions
- Stable Myopic Refractive Error, With or Without Astigmatism
Interventions
STAR S4 IR laser with iDesignDevice
Surgeons will perform wavefront-guided PRK for the treatment of myopic refractive errors based upon measurements obtained with the iDesign System using the STAR S4 IR laser.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Percentage of Eyes Achieving the Target of Monocular Uncorrected Visual Acuity of 20/40 or BetterTime frame: 6 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.